![](/img/cover-not-exists.png)
An Observational Study of Survival in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After 1, 3, and 5 Years of Tyrosine Kinase Inhibitor (TKI) Therapy (SIMPLICITY)
Michallet, Mauricette, Cortes, Jorge, Gambacorti-Passerini, Carlo, Hehlmann, Rüdiger, Williams, Loretta A., Goldberg, Stuart L., Davis, Catherine, De Solda, Francesco, Sen, Ginny P., Gajavelli, SrikanVolume:
18
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2018.07.105
Date:
September, 2018
File:
PDF, 68 KB
english, 2018